drugset / Trial / NCT00395421
Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is being conducted to see if the investigational medication, valopicitabine, is safe to use in combination with ribavirin, a drug approved by the FDA for treating hepatitis C infection.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-06
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | valopicitabine | Unknown | 200 mg | — |
| Background | Peginterferon alfa-2a | Protein / enzyme biologic | 180 ug | — |